Table 4

Metabolic parameters at the end of the 6 month low and high dairy phases
Variable Endpoint % change Endpoint % change
LD1 LD2 HD1 HD2
Body weight (kg) 86.2 ± 8.6 2.1 ± 1.2 87.0 ± 8.2 2.4 ± 1.3
Waist circumference (cm) 100.7 ± 13.3 1.0 ± 2.3 98.2 ± 7.3 1.2 ± 2.2
Total body fat (%) 45.4 ± 9.4 1.9 ± 2.1 45.0 ± 8.6 2.7 ± 2.3
Abdominal fat (%) 44.8 ± 9.02 2.1 ± 2.62 44.9 ± 7.82 1.2 ± 1.53
Systolic blood pressure (mm/Hg) 124.1 ± 16.2 2.5 ± 3.2 121.5 ± 14.6 4.8 ± 2.5
Diastolic blood pressure (mm/Hg) 78.5 ± 16.0 0.7 ± 2.6 76.6 ± 9.4 2.3 ± 2.6
Glucose (mmol/L) 5.2 ± 0.7 3.8 ± 1.5 5.2 ± 0.7 2.1 ± 1.9
Insulin (μU/mL) 16.2 ± 3.7 10.0 ± 3.2 14.8 ± 2.4* 2.5 ± 2.2¥
HOMA-IR 3.8 ± 1.3 16.5 ± 4.6 3.4 ± 0.9* 5.1 ± 2.8¥
Total cholesterol (mmol/L) 5.4 ± 0.9 1.1 ± 3.1 5.6 ± 0.8 3.1 ± 2.4
LDL-cholesterol (mmol/L) 3.3 ± 0.8 -1.2 ± 2.1 3.4 ± 0.8 3.9 ± 5.1
HDL-cholesterol (mmol/L) 1.4 ± 0.3 4.6 ± 2.3 1.4 ± 0.4 8.4 ± 3.4
Triglycerides (mmol/L) 1.8 ± 0.7 -0.05 ± 8.7 1.7 ± 0.6 -3.8 ± 10.1
ApoB (mg/dl) 90.7 ± 20.1 2.1 ± 1.8 92.5 ± 19.6 3.2 ± 4.5
ApoE (mg/dl) 5.4 ± 0.5 -2.5 ± 1.1 5.3 ± 0.8 -4.8 ± 2.6
Lp(a) (mg/dl) 37.3 ± 37.9 -9.4 ± 6.2 48.1 ± 13.1 -0.05 ± 7.4
ApoCII (mg/dl) 6.5 ± 1.7 10.1 ± 3.9 6.2 ± 1.9 2.6 ± 3.9
Metabolic rate (kJ/min) 2.8 ± 0.7 1.0 ± 3.9 2.7 ± 0.8 4.9 ± 4.3
Carbohydrate oxidation (g/min) 0.01 ± 0.04 3.6 ± 1.7 0.03 ± 0.05 6.8 ± 3.2
Fat oxidation (g/min) 0.07 ± 0.02 3.8 ± 0.02 0.06 ± 0.02 9.6 ± 10.9

1Endpoint values adjusted for baseline levels within period; mean ± SD; n = 23 LD; n = 23 HD.

2% change from baseline values were calculated using phase 1, d-1.

*P < 0.05 compared with endpoint LD; ¥P < 0.05 compared with % change from baseline LD.

Rideout et al.

Rideout et al. Nutrition Journal 2013 12:56   doi:10.1186/1475-2891-12-56

Open Data